Right ventricular (RV) as well as left ventricular (LV) function has been recognized as an important prognostic factor for heart failure patients. Our objective was thus to investigate the prognostic significance of combined assessment of bi-ventricular functional reserve for patients with dilated cardiomyopathy (DCM).
Introduction
Despite recent advances in heart failure (HF) therapy, the overall prognosis for symptomatic patients with dilated cardiomyopathy (DCM) remains unsatisfactory. It is thus important to identify patients with poor prognoses who are likely to experience clinical deterioration, because they may require a more targeted treatment approach. Dobutamine stress echocardiography is being widely used to assess left ventricular (LV) myocardial viability and patients' prognosis, and its safety and usefulness have been well established. 1, 2 Although DCM is generally thought to be accompanied by both LV and right ventricular (RV) myocardial impairment, 3 until recently the main focus of functional assessment has been on the LV. However, emerging evidence has shown that the RV is far more than a 'passive conduit' or a 'silent bystander' of the LV and that it may play a key pathophysiological role in patients with HF. 4 -8 For patients with advanced HF in particular, the coexistence of RV and LV dysfunction is associated with poorer exercise capacity 6 and reduced survival 9 than is LV dysfunction alone. However, the prognostic significance of RV functional reserve for patients with HF remains unclear. We therefore investigated the prognostic impact of RV contractile reserve on patients with DCM, and tested the hypothesis that combined assessment of bi-ventricular contractile reserve can lead to further improvement of prognostic evaluation.
Methods

Study population
We recruited 120 consecutive patients with symptomatic HF due to DCM for this study. Ten of these patients (8%) were excluded from all subsequent analyses because of suboptimal quality of images as were six patients (5%) with atrial fibrillation. Exclusion criteria also included the presence of other major cardiac arrhythmia, more than moderate organic valvular disease. The final study population thus comprised 104 patients. The diagnosis of DCM was established on the basis of the following criteria: (i) presence of LV dilation (LV end-diastolic diameter ≥55 mm); (ii) reduced LV ejection fraction (EF) (all %45%); (iii) coronary angiographic evidence of absence of coronary artery disease defined as .50% stenosis of a major epicardial vessel or a history of myocardial infarction; and (iv) absence of cardiac muscle disease secondary to any known systemic diseases. No patients received cardiac resynchronization therapy nor did an LV assist device. At the time of enrolment, all patients were in clinically stable condition and undergoing optimal and maximally tolerated pharmacological therapy. This study was approved by the local ethics committee of our institution, and written informed consent was obtained from all patients.
Standard echocardiographic examination
Standard echocardiography was performed with a commercially available ultrasound system (Aplio Artida; Toshiba Medical Systems, Tochigi, Japan), equipped with a 3.0-MHz transducer. Standard LV measurements were obtained from the parasternal long-axis, short-axis, and standard apical views in accordance with the current guidelines of the American Society of Echocardiography. 10 LV volumes and EF were calculated with the biplane Simpson's method, and all volumes and LV mass measurements were then normalized to body surface area.
In accordance with the recommendations of the American Society of Echocardiography, 11 the RV end-diastolic area, end-systolic area, and fractional area change (RVFAC) were measured from the RV-focused four-chamber view. An M-mode cursor was oriented to the junction of the tricuspid valve and the RV free wall to measure tricuspid annular plane systolic excursion (TAPSE). The myocardial performance index (MPI) was obtained for both RV and LV by dividing the sum of isovolumic contraction and relaxation times by the ejection time using pulsed-wave Doppler method. 11 Pulmonary artery systolic pressure was estimated from the peak velocity of the tricuspid regurgitation jet plus estimated mean right atrial pressure. 11
Speckle-tracking strain analysis
Digital two-dimensional (2D) grey-scale data were obtained at baseline and during peak dobutamine infusion. Speckle-tracking analyses of both LV and RV were performed with dedicated software (Ultra Extend; Toshiba Medical Systems), as described previously in detail, 12 and each speckle-tracking strain parameter was expressed as an absolute value. Briefly, circumferential strain was assessed from the mid-LV short-axis view ( Figure 1A) , and the average value of regional strain at each time point was calculated to obtain the global circumferential strain (GCS). Similarly, the average values of the longitudinal strain from three apical views were calculated to obtain the global longitudinal strain (GLS) from each apical view.
RV myocardial deformation was assessed in terms of longitudinal strain by using a routine grey-scale RV-focused view. GLS from the RV free wall (RV-free) was calculated by averaging each of the three regional systolic strains from the RV free wall at the RV-focused apical four-chamber view 12 -14 (Figure 1B ).
Dobutamine stress test
All patients underwent dobutamine stress echocardiography in incremental stages lasting 5 min each. The initial dose was 5 mg/kg/min and was increased first to 10 mg/kg/min and finally to the maximal dose of 20 mg/kg/min. 15 LV contractile reserve was defined as the relative change between baseline GCS, GLS, LV wall motion score index (WMSI), and LVEF and their values obtained at peak stress (DGCS, DGCS, DWMSI, and DLVEF, respectively), and RV contractile reserve was defined as the relative change in RVFAC, TAPSE, and RV-free from rest to peak stress (DRVFAC, DTAPSE, and DRV-free, respectively).
Long-term follow-up analysis
Long-term unfavourable events were pre-specified as primary end points of death from or hospitalization for deteriorating HF, and sudden cardiac death. Long-term follow-up was conducted for 17.2 months.
Statistical analyses
Continuous variables were expressed as mean values + SD or percentages for normal distribution. For non-normally distributed data, the median and inter-quartile ranges are shown. The parameters of the two subgroups were compared by using the unpaired t-test, and the paired t-test was used for comparison of continuous variables. Proportional differences were evaluated by means of Fisher's exact test or the x 2 test as appropriate. Receiver-operating characteristic (ROC) curves were constructed to determine the optimal cut-off points for the cardiovascular events. The Kaplan-Meier curve was constructed to assess cardiovascular event-free survival during the follow-up period, and event rates were compared by means of the log-rank test. The associations of clinical and echocardiographic parameters with cardiovascular events were identified by the Cox proportional-hazards model for both univariate and multivariate analyses. In the selection of the univariate variables, all the established clinical and echocardiographic prognostic markers were selected as dependent variables regardless of the results of the group comparisons. Variables with a univariate value of P , 0.10 were incorporated into the stepwise selection, while age and gender were forced into the multivariate analysis regardless of their association on univariate analysis. In the stepwise selection, variables were eliminated from the model if a P-value of Score test statistics ,0.05, while variables were selected into the model if a P-value of Wald test statistics more than 0.05. To avoid collinearity in situations where more than two variables measured a pathophysiological parameter (e.g. LV endsystolic volume index and LV EF as markers of LV contraction), clinically more relevant parameter was entered into stepwise selection. Furthermore, Cox models were compared to determine the increase in prognostic benefit of bi-ventricular contractile reserve during dobutamine stress in comparison with clinical and baseline echocardiographic variables. A statistically significant increase in the global log-likelihood x 2 of the model was interpreted as representing an improvement in prognostic value. Inter-and intra-observer variability was expressed as the absolute difference between repeated measurements divided by their mean value from 10 randomly selected patients. For all steps, a P-value of ,0.05 was considered statistically significant. MedCalc 12.3.0 (MedCalc Software, Mariakerke, Belgium) was used for statistical analysis.
Results
Baseline characteristics
Of the 104 patients who met all inclusion criteria, none were lost to follow-up. During the median follow-up period of 17.2 months (inter-quartile range: 5.5 -34.1 months) after enrolment, adverse cardiovascular events developed in 21 patients (20%), with 2 patients dying of HF, 4 of sudden cardiac death, and the remaining 15 being hospitalized due to worsening HF.
The baseline clinical and echocardiographic characteristics of the patients are presented in Table 1 . No significant differences between the two subgroups were noted in terms of age, gender distribution, comorbidities, and baseline haemodynamic parameters. However, patients with cardiovascular events were more likely to have higher brain natriuretic peptide concentration and were more often prescribed loop diuretics at baseline. With respect to the baseline echocardiographic characteristics, patients with cardiovascular events were more likely to have larger LV volumes and a smaller LVEF, higher WMSI, larger left atrial (LA) volume index, and higher Figure 1 (A) GCS was assessed from the mid-LV short-axis view, and the average value of the regional strain at each time point was calculated.
(B) RV free-wall longitudinal speckle tracking strain (RV-free) was calculated by using the RV-focused view for averaging the three regional peak systolic strains (basal, middle, and apical lateral) from the RV free wall. E/A ratio, suggesting the presence of more severe HF at baseline. On the other hand, there were no significant differences between these two subgroups regarding the RV functional and morphological parameters at baseline. Table 2 shows the changes in haemodynamic and echocardiographic parameters under dobutamine stress. As for the echocardiographic indices of LV function, all functional parameters increased significantly in response to dobutamine in patients without cardiovascular events, but these responses were blunted in patients with cardiovascular events. It should also be noted that all RV functional parameters were significantly augmented in patients without cardiovascular events, but that such responses were not observed in patients with cardiovascular events (Figure 2 ).
Dobutamine stress echocardiography
Prognostic factor of cardiovascular events
The hazard ratio (HR) and 95% confidence interval (CI) for each of the variables of the univariate and multivariate Cox proportionalhazards analyses are shown in Table 3 . An important finding of the multivariate analysis showed that baseline EF, E/A ratio, DEF, DGCS, and DRV-free were independently associated with cardiovascular events ( Table 3) . Of the Cox models, a model based on baseline clinical and echocardiographic variables (model 1: age, gender, EF, and E/A, x 2 ¼ 23.6) was improved by the addition of LV contractile reserve parameters (model 2: plus DGCS and DEF, x 2 ¼ 49.1; P , 0.001) and further improved by addition of changes in RVfree under dobutamine stress (model 3: plus DRV-free, x 2 ¼ 60.3; P , 0.001) (Figure 3) .
Based on the findings of ROC curve analyses, we divided the patients into three subgroups based on the presence or absence of LV (DGCS: cut-off value of 13.7%) and RV (DRV-free: cut-off value of 16.5%) contractile reserve (Figure 4) . There were 60 patients showing both LV and RV contractile reserve (i.e. patients with bi-ventricular contractile reserve), and this pattern was associated with the most favourable event-free survival among the three subgroups. Conversely, 18 patients who showed neither LV nor RV contractile reserve (i.e. patients without bi-ventricular contractile reserve) constituted the subgroup with the worst cardiovascular event-free rate. In addition, there were 26 patients with a 'ventricular discordant' pattern, who showed either LV or RV contractile reserve alone. This pattern was associated with intermediate risk of cardiovascular events. Figure 5 shows representative cases of DCM with and without cardiovascular event.
Reproducibility of measurements
The intra-observer reproducibility values were 4.2% for baseline GCS, 3.5% for dobutamine stress GCS, 3.5% for baseline GLS, Figure 2 Bar graphs comparing the responses of the RV functional parameters to dobutamine stress for patients with and without cardiovascular events. 4.4% for dobutamine stress GLS, 5.6% for baseline RV-free, and 6.5% for dobutamine stress RV-free, and the corresponding interobserver reproducibility values were 5.4, 5.3, 7.7, 5.8, 7.1, and 6.6%, respectively.
Discussion
The study reported here is the first to demonstrate the prognostic capability of not only LV, but also RV contractile reserve assessed by means of quantitative 2D speckle-tracking strain during dobutamine stress for patients with DCM. Both LV and RV contractile reserves were identified as the independent parameters associated with cardiovascular events, and these parameters produced incremental prognostic value compared with clinical and baseline echocardiographic parameters. Furthermore, the combined assessment of LV and RV contractile reserve proved to be useful for prognostic risk stratification of patients with DCM.
Utility of the assessment of RV function in HF patients
The role of RV function in different cardiovascular diseases has been increasingly recognized and there is a growing body of evidence that RV function is a powerful predictor of mortality for HF patients. 5 -9,16 On the other hand, when venous return to the right heart, the pulmonary vascular circuit, and LV systolic and diastolic function are all normal, the RV may be no more than a relatively 'passive conduit', as seen in patients after Fontan palliation. 17 In fact, patients with Fontan circulation have relatively preserved resting cardiac output even though they do not have a functioning subpulmonary ventricle, which would seem to indicate that the RV is an 'unnecessary part of the heart'. However, once systemic ventricular dysfunction develops, or pulmonary vascular resistance increases, this unique circulation without a subpulmonary ventricle tends to fail easily. Thus, one can speculate that the clinical importance of RV function becomes evident only after the development of LV dysfunction or All other abbreviations as in Table 1 . HR, hazard ratio; CI, confidential interval.
increased pulmonary vascular resistance. A key clinical problem is therefore the extent to which the RV can adapt to changes in haemodynamic conditions, especially in patients with reduced LV function.
Interrelationship of bi-ventricular function in patients with DCM
Ejection of blood from the RV consists of three separate mechanisms, namely, the inward movement of the RV free wall along with the interventricular septal bulging into the RV chamber (i.e. the bellows effect), traction on the RV free wall at the points of attachment secondary to LV contraction (i.e. the traction effect), and contraction of the longitudinal fibres of the RV free wall. We previously reported that myocardial systolic dysfunction of patients with DCM shows a consistently heterogeneous regional distribution with septal dominancy. 18 This means that in patients with DCM, not only will the bellows effect of the ventricular septum, but also the effect of RV traction resulting from LV contraction be greatly reduced because of global LV dysfunction with myocardial damage due to septal dominancy. One can therefore speculate that RV function may be much more dependent on the longitudinal shortening of the RV free wall in patients with DCM. These findings and speculations could explain why RV contractile reserve assessed in terms of RV-free was found to be associated with cardiovascular events in our patient population.
Clinical utility of the assessment of bi-ventricular functional reserve in HF patients
Dobutamine stress echocardiography is an established method for the assessment of myocardial viability and prognosis of patients with HF. 1, 2, 19 However, direct assessment of the WMSI or LVEF during dobutamine stress has been found to be subjective as well as highly load dependent, while its accuracy depends largely on the experience of the operators. 20, 21 For these reasons, the automated quantification of myocardial function during stress testing has been looked forward to for a long time, because it would eliminate the subjective nature associated with visual assessment. In this study, we found that the change in GCS during dobutamine stress was the robust prognostic parameter for LV function in patients with DCM. On the other hand, despite the utility of assessing resting RV function in HF patients, only a few studies have been done of the prognostic value of the assessment of RV contractile reserve in these patients. Gorcsan et al. 22 reported that preserved RV contractile reserve, assessed by means of pressure-area relations induced by low-dose dobutamine infusion, was associated with 30-day outcome for 16 patients with advanced HF awaiting heart transplantation. Otasevic et al. 23 also performed dobutamine stress echocardiography on 48 severe HF patients, and assessed the prognostic implications of both LV and RV contractile reserve. Although these studies have suggested the prognostic significance of dobutamine-induced RV contractile reserve, they assessed RV function by means of RV area tracing, which is characterized by a critical lack of accuracy and reproducibility. In our study, on the other hand, with a larger patient population and longer follow-up, RV in addition to LV contractile reserve, assessed with the quantitative 2D speckle-tracking system, was identified as an independent parameter associated with cardiovascular events. Our findings thus suggest the possibility that both LV and RV functional reserve are required for a favourable outcome for patients with systolic HF, so that estimation of RV contractile reserve should be considered part of a comprehensive assessment of these patients.
Study limitations
There are certain limitations to this study. First, this pilot study covered a relatively small number of patients with a relatively short-term follow-up, so that further studies with larger patient populations and longer follow-up will be needed to validate our findings. Secondly, dobutamine stress echocardiography was performed with the maximal dose of 20 mg/kg/min in this study, and low-dose dobutamine may not recruit full contractile potential, especially in the patients who are taking b-blockers. On the other hand, some of the previous investigators used high doses of dobutamine protocol in this ill group of the patients. And the complication rate of high-dose dobutamine has been reported up to 37%, including non-sustained ventricular tachycardia or supraventricular tachyarrhythmia. 1 However, in this study, only one patient (1%) experienced non-sustained ventricular tachycardia, which resolved soon after the discontinuation of dobutamine infusion. Thus, from the safety point of view, we believe low-dose dobutamine protocol may rather be preferable for these patients. Thirdly, there were significant differences in some baseline parameters between groups. We think this may partially reflect disease severity in the patients with cardiovascular events at baseline. However, these variables were not selected as independent predictors of cardiovascular events in the multivariate Cox analysis. Thus, we believe that the differences in the baseline characteristics between groups would not have significant effect on the overall results of this study.
Conclusions
RV contractile reserve in addition to LV reserve was found to be associated with significant prognostic impact for patients with DCM. Combined assessment of bi-ventricular functional reserve offers an even better prognostic value and may lead to more targeted therapy for the patients with DCM.
